United States · FDA National Drug Code directory

AbbVie Inc.

Labeler · 96 source records

The organisation role is retained from the source. Companies with similar names in other sources are not automatically merged.

United States · Source reference 0032-0045_a43ddd93-7d01-4bb9-95e3-b0629fe8ac87

Creon

CAPSULE, DELAYED RELEASE / AbbVie Inc.

United States · Source reference 0032-0046_a43ddd93-7d01-4bb9-95e3-b0629fe8ac87

Creon

CAPSULE, DELAYED RELEASE PELLETS / AbbVie Inc.

United States · Source reference 0032-0047_a43ddd93-7d01-4bb9-95e3-b0629fe8ac87

Creon

CAPSULE, DELAYED RELEASE PELLETS / AbbVie Inc.

United States · Source reference 0032-1203_a43ddd93-7d01-4bb9-95e3-b0629fe8ac87

Creon

CAPSULE, DELAYED RELEASE / AbbVie Inc.

United States · Source reference 0032-1206_a43ddd93-7d01-4bb9-95e3-b0629fe8ac87

Creon

CAPSULE, DELAYED RELEASE PELLETS / AbbVie Inc.

United States · Source reference 0032-1212_a43ddd93-7d01-4bb9-95e3-b0629fe8ac87

Creon

CAPSULE, DELAYED RELEASE PELLETS / AbbVie Inc.

United States · Source reference 0032-1224_a43ddd93-7d01-4bb9-95e3-b0629fe8ac87

Creon

CAPSULE, DELAYED RELEASE PELLETS / AbbVie Inc.

United States · Source reference 0032-2636_a43ddd93-7d01-4bb9-95e3-b0629fe8ac87

Creon

CAPSULE, DELAYED RELEASE PELLETS / AbbVie Inc.

United States · Source reference 0032-2637_a43ddd93-7d01-4bb9-95e3-b0629fe8ac87

Creon

CAPSULE, DELAYED RELEASE PELLETS / AbbVie Inc.

United States · Source reference 0032-3016_a43ddd93-7d01-4bb9-95e3-b0629fe8ac87

Creon

CAPSULE, DELAYED RELEASE PELLETS / AbbVie Inc.

United States · Source reference 0074-0282_a7f31acd-4120-420a-ab5d-10415866e41a

DECNUPAZ

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / AbbVie Inc.

United States · Source reference 0074-7325_7cc3a0b3-93f8-4825-88e1-bf6ddb0db23d

Depakote

TABLET, DELAYED RELEASE / AbbVie Inc.

United States · Source reference 0074-7326_7cc3a0b3-93f8-4825-88e1-bf6ddb0db23d

Depakote

TABLET, DELAYED RELEASE / AbbVie Inc.

United States · Source reference 0074-7327_7cc3a0b3-93f8-4825-88e1-bf6ddb0db23d

Depakote

TABLET, DELAYED RELEASE / AbbVie Inc.

United States · Source reference 0074-7401_0ee65b66-ead3-44ef-911f-14965b067903

Depakote ER

TABLET, EXTENDED RELEASE / AbbVie Inc.

United States · Source reference 0074-7402_0ee65b66-ead3-44ef-911f-14965b067903

Depakote ER

TABLET, EXTENDED RELEASE / AbbVie Inc.

United States · Source reference 0074-6114_d038b7e9-b014-4771-93be-90aeeaece03d

Depakote Sprinkles

CAPSULE / AbbVie Inc.

United States · Source reference 0074-3012_3141c7d9-a3c8-4658-8a14-22182f452465

Duopa

SUSPENSION / AbbVie Inc.

United States · Source reference 0074-3878_35d361ac-c141-4544-bb6a-a6c308d64497

EMBLAVEO

POWDER, FOR SOLUTION / AbbVie Inc.

United States · Source reference 0074-1044_998985bb-7cd1-4e80-bd08-8fc7c503f982

EMRELIS

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / AbbVie Inc.

United States · Source reference 0074-1055_998985bb-7cd1-4e80-bd08-8fc7c503f982

EMRELIS

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / AbbVie Inc.

United States · Source reference 0074-3108_38f517b9-c5d1-479a-9117-f65ea1d479d4

Gengraf

CAPSULE / AbbVie Inc.

United States · Source reference 0074-3109_38f517b9-c5d1-479a-9117-f65ea1d479d4

Gengraf

CAPSULE / AbbVie Inc.

United States · Source reference 0074-0124_8bf84b15-6763-41cf-bfa4-bcee9ad4ef9a

Humira

KIT / AbbVie Inc.

United States · Source reference 0074-0243_8bf84b15-6763-41cf-bfa4-bcee9ad4ef9a

Humira

KIT / AbbVie Inc.

United States · Source reference 0074-0554_8bf84b15-6763-41cf-bfa4-bcee9ad4ef9a

Humira

KIT / AbbVie Inc.

United States · Source reference 0074-0616_8bf84b15-6763-41cf-bfa4-bcee9ad4ef9a

Humira

KIT / AbbVie Inc.

United States · Source reference 0074-0817_8bf84b15-6763-41cf-bfa4-bcee9ad4ef9a

Humira

KIT / AbbVie Inc.

United States · Source reference 0074-1539_8bf84b15-6763-41cf-bfa4-bcee9ad4ef9a

Humira

KIT / AbbVie Inc.

United States · Source reference 0074-2540_8bf84b15-6763-41cf-bfa4-bcee9ad4ef9a

Humira

KIT / AbbVie Inc.

Browse companies in United States →